Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System

American Journal of Gastroenterology

Volumn 112, Issue 2, 2017, Pages 375-382

  Issaka, Rachel B ^a   Singh, Maneesh H ^a   Oshima, Sachiko M ^a   Laleau, Victoria J ^a   Rachocki, Carly D ^a   Chen, Ellen H ^b   Day, Lukejohn W ^a   Sarkar, Urmimala ^a   Somsouk, Ma ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Public Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG; HEMOGLOBIN;

ABNORMAL LABORATORY RESULT; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; ELECTRONIC HEALTH RECORD; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; FOLLOW UP; GASTROENTEROLOGY; HIGH RISK PATIENT; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD REVIEW; MIDDLE AGED; MULTICENTER STUDY; PATIENT COUNSELING; PATIENT REFERRAL; PREDICTIVE VALUE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SAFETY NET HOSPITAL; SCREENING TEST; SUBSTANCE USE; AFRICAN AMERICAN; AMBULATORY CARE; ASIAN AMERICAN; CALIFORNIA; CAUCASIAN; CHEMISTRY; COLORECTAL NEOPLASMS; COUNSELING; DOCUMENTATION; EARLY CANCER DIAGNOSIS; ETHNIC GROUP; FECES; HEALTH INSURANCE; HISPANIC; LANGUAGE; MARRIAGE; MULTIVARIATE ANALYSIS; OUTPATIENT DEPARTMENT; PRIMARY HEALTH CARE; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; TIME FACTOR; UTILIZATION;

AFRICAN AMERICANS; AGED; AMBULATORY CARE; AMBULATORY CARE FACILITIES; ASIAN AMERICANS; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; COMORBIDITY; COUNSELING; DOCUMENTATION; EARLY DETECTION OF CANCER; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FECES; FEMALE; GASTROENTEROLOGY; HEMOGLOBINS; HISPANIC AMERICANS; HUMANS; INSURANCE, HEALTH; LANGUAGE; LOGISTIC MODELS; MALE; MARITAL STATUS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; SAN FRANCISCO; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 85011632864     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.555     Document Type: Article

References (49)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7-30.
2. Baxter NN, Goldwasser MA, Paszat LF et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009; 150: 1-8.
3. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-71.
4. Selby JV, Friedman GD, Quesenberry CP Jr et al. Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med 1993; 118: 1-6.
5. Cyhaniuk A, Coombes ME. Longitudinal adherence to colorectal cancer screening guidelines. Am J Manag Care 2016; 22: 105-11.
6. Etzioni DA, Ponce NA, Babey SH et al. A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey. Cancer 2004 101: 2523-32.
7. Liss DT, Baker DW. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care. Am J Prev Med 2014; 46: 228-36.
8. Gupta S, Tong L, Allison JE et al. Screening for colorectal cancer in a safetynet health care system: access to care is critical and has implications for screening policy. Cancer Epidemiol Biomarkers Prev 2009; 18: 2373-9.
9. Klabunde CN, Cronin KA, Breen N et al. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev 2011; 20: 1611-21.
10. Ho C, Kornfeld R, Vittinghoff E et al. Late presentation of colorectal cancer in a vulnerable population. Am J Gastroenterol 2013; 108: 466-70.
11. Inadomi JM, Vijan S, Janz NK et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 2012; 172: 575-82.
12. Singal AG, Gupta S, Tiro JA et al. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: a randomized controlled trial in a safety-net health system. Cancer 2016; 122: 456-63.
13. Day LW, Bhuket T, Inadomi JM et al. Diversity of endoscopy center operations and practice variation across California's safety-net hospital system: a statewide survey. BMC Res Notes 2013; 6: 233.
14. Jensen CD, Corley DA, Quinn VP et al. Fecal immunochemical test program performance over 4 rounds of annual screening: a retrospective cohort study. Ann Intern Med 2016; 164: 456-63.
15. Chiu HM, Chen SL, Yen AM et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer 2015; 121: 3221-9.
16. Bibbins-Domingo K, Grossman DC, Curry SJ et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2016; 315: 2564-75.
17. Crouse AL, De Koning L, Sadrzadeh SM et al. Sensitivity and specifcity of community fecal immunotesting screening for colorectal carcinoma in a high-risk canadian population. Arch Pathol Lab Med 2015; 139: 1441-5.
18. Jensen CD, Quinn VP, Doubeni CA et al. Colonoscopy Delay After a Positive Fecal Test and Risk of Colorectal Cancer-Related Outcomes. Paper presented at: Digestive Diseases Week San Diego, CA, USA 2016.
19. Attachment Q-PRIME Projects and Metrics Protocol. California Department of Health Care Services 2015; 41: http://www.dhcs.ca.gov/provgovpart/Documents/MC2020-AttachmentQ-PRIMEProjectsMetrics.pdf. Accessed on 12 August 2016.
20. Katz MH, Brigham TM. Transforming a traditional safety net into a coordinated care system: lessons from healthy San Francisco. Health Aff (Millwood) 2011; 30: 237-45.
21. San Francisco General Hospital & Trauma Center Annual Report Fiscal Year 2014-2015 2015, https://www.sfdph.org/dph/files/hc/HCAgen/HCAgen2015/Nov 17/04b SFGH-AnnualReport2014-2015-draf 20151110-1.pdf; accessed on 1 July 2016.
22. Chen AH, Kushel MB, Grumbach K et al. Practice profile. A safety-net system gains efciencies through 'eReferrals' to specialists. Health Aff (Millwood) 2010; 29: 969-71.
23. Chen AH, Murphy EJ, Yee HF Jr. eReferral-a new model for integrated care. N Engl J Med 2013; 368: 2450-3.
24. Tuot DS, Murphy EJ, McCulloch CE et al. Leveraging an electronic referral system to build a medical neighborhood. Healthc (Amst) 2015; 3: 202-8.
25. Price EL, Sewell JL, Hm Chen A et al. Minding the gaps: assessing communication outcomes of electronic preconsultation exchange. Jt Comm J Qual Patient Saf 2016; 42: 341-54.
26. Chiu HM, Lee YC, Tu CH et al. Association between early stage colon neoplasms and false-negative results from the fecal immunochemical test. Clin Gastroenterol Hepatol 2013; 11: 832-8, e831-832.
27. Baig N, Myers RE, Turner BJ et al. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol 2003; 98: 2078-81.
28. Crotta S, Segnan N, Paganin S et al. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol 2012; 10: 633-8.
29. Myers RE, Turner B, Weinberg D et al. Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. Prev Med 2004; 38: 375-81.
30. Parente F, Boemo C, Ardizzoia A et al. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy. Endoscopy 2013; 45: 27-34.
31. Oluloro A, Petrik AF, Turner A et al. Timeliness of colonoscopy after abnormal fecal test results in a safety net practice. J Community Health 2016; 41: 864-70.
32. El-Haddad B, Dong F, Kallail KJ et al. Association of marital status and colorectal cancer screening participation in the USA. Colorectal Dis 2015; 17: O108-14.
33. von Euler-Chelpin M, Brasso K, Lynge E. Determinants of participation in colorectal cancer screening with faecal occult blood testing. J Public Health (Oxf) 2010; 32: 395-405.
34. Sewell JL, Kushel MB, Inadomi JM et al. Non-English speakers attend gastroenterology clinic appointments at higher rates than English speakers in a vulnerable patient population. J Clin Gastroenterol 2009; 43: 652-60.
35. Carlson CM, Kirby KA, Casadei MA et al. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up? Arch Intern Med 2011; 171: 249-56.
36. Zapka JM, Edwards HM, Chollette V et al. Follow-up to abnormal cancer screening tests: considering the multilevel context of care. Cancer Epidemiol Biomarkers Prev 2014; 23: 1965-73.
37. Laxmisan A, Sittig DF, Pietz K et al. Effectiveness of an electronic health record-based intervention to improve follow-up of abnormal pathology results: a retrospective record analysis. Med Care 2012; 50: 898-904.
38. Singh H, Arora HS, Vij MS et al. Communication outcomes of critical imaging results in a computerized notifcation system. J Am Med Inform Assoc 2007; 14: 459-66.
39. Khoury MJ, Iademarco MF, Riley WT. Precision public health for the era of precision medicine. Am J Prev Med 2016; 50: 398-401.
40. Canin L, Wunsch B. Specialty Care in the Safety Net: Efforts to Expand Timely Access. 2009:20 http://www.chcf.org/~/media/MEDIA LIBRARY Files/PDF/PDF S/PDF SpecialtyCareOverview.pdf. Accessed on 1 July 2016.
41. Gusmano MK, Fairbrother G, Park H. Exploring the limits of the safety net: community health centers and care for the uninsured. Health Aff (Millwood) 2002; 21: 188-94.
42. Woolf SH, Braveman P. Where health disparities begin: the role of social and economic determinants-and why current policies may make matters worse. Health Aff (Millwood) 2011; 30: 1852-9.
43. Chubak J, Garcia MP, Burnett-Hartman AN et al. Time to colonoscopy after positive fecal blood test in four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev 2016; 25: 344-50.
44. Chen LA, Santos S, Jandorf L et al. A program to enhance completion of screening colonoscopy among urban minorities. Clin Gastroenterol Hepatol 2008; 6: 443-50.
45. Ladabaum U, Mannalithara A, Jandorf L et al. Cost-Effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals. Cancer 2015; 121: 1088-97.
46. Singh H, Kadiyala H, Bhagwath G et al. Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results. Am J Gastroenterol 2009; 104: 942-52.
47. Jandorf L, Braschi C, Ernstoff E et al. Culturally targeted patient navigation for increasing african americans' adherence to screening colonoscopy: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2013; 22: 1577-87.
48. Braschi CD, Sly JR, Singh S et al. Increasing colonoscopy screening for Latino Americans through a patient navigation model: a randomized clinical trial. J Immigr Minor Health 2014; 16: 934-40.
49. Baker DW, Brown T, Buchanan DR et al. Design of a randomized controlled trial to assess the comparative Effectiveness of a multifaceted intervention to improve adherence to colorectal cancer screening among patients cared for in a community health center. BMC Health Serv Res 2013; 13: 153.